La comparación de medias para dos grupos independientes fue realizada con la prueba t de Student con un grado de significación (p) de 0,05. La comparación estadística para más de dos grupos fue realizada con el análisis de varianza (ANOVA). Para la comparación de los valores obtenidos (medias) se utilizó el test de Menor Diferencia Significativa (LSD) con un grado de significación (p) de 0,05.
94
2.19. Referencias
1. Stainer DW, Scholte MJ. A Simple Chemically Defined Medium for the Production of Phase I Bordetella pertussis. Microbiology. 1970,63(2):211-220.
2. Simon R, Priefer U, Puhler A. A Broad Host Range Mobilization System for In Vivo Genetic Engineering: Transposon Mutagenesis in Gram Negative Bacteria. Nat Biotech. 1983,1(9):784-791.
3. Inatsuka CS, Xu Q, Vujkovic-Cvijin I, Wong S, Stibitz S, Miller JF, Cotter PA. Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect Immun. 2010,78(7):2901-2909.
4. Kovach ME, Phillips RW, Elzer PH, Roop RM, 2nd, Peterson KM. pBBR1MCS: a broad- host-range cloning vector. BioTechniques. 1994,16(5):800-802.
5. Vidakovics ML, Paba J, Lamberti Y, Ricart CA, de Sousa MV, Rodriguez ME. Profiling the Bordetella pertussis proteome during iron starvation. J Proteome Res. 2007,6(7):2518-2528.
6. Schwyn B, Neilands J. Universal chemical assay for the detection and determination of siderophores. Anal Biochem. 1987,160(1):47-56.
7. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, Gruenert DC. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol. 1994,10(1):38-47. 8. Hellwig SM, van Oirschot HF, Hazenbos WL, van Spriel AB, Mooi FR, van De Winkel JG. Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. J Infect Dis. 2001,183(6):871-879.
9. Alvarez Hayes J, Erben E, Lamberti Y, Principi G, Maschi F, Ayala M, Rodriguez ME.
Bordetella pertussis iron regulated proteins as potential vaccine components. Vaccine.
2013,31(35):3543-3548.
10. Alvarez Hayes J, Erben E, Lamberti Y, Ayala M, Maschi F, Carbone C, Gatti B, Parisi G, Rodriguez ME. Identification of a new protective antigen of Bordetella pertussis.
Vaccine. 2011,29(47):8731-8739.
11. Lamberti Y, Estudio de la interacción de Bordetella pertussis con células del hospedador. 2010, Facultad de Ciencias Exactas.
12. Lee CK, Roberts AL, Finn TM, Knapp S, Mekalanos JJ. A new assay for invasion of HeLa 229 cells by Bordetella pertussis: effects of inhibitors, phenotypic modulation, and genetic alterations. Infect Immun. 1990,58(8):2516-2522.
13. Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H (+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem. 1991,266(26):17707-17712.
14. Rodriguez ME, Hellwig SM, Hozbor DF, Leusen J, van der Pol WL, van de Winkel JG. Fc receptor-mediated immunity against Bordetella pertussis. J Immunol. 2001,167(11):6545-6551.
15. Lamberti YA, Hayes JA, Perez Vidakovics ML, Harvill ET, Rodriguez ME. Intracellular trafficking of Bordetella pertussis in human macrophages. Infect Immun. 2010,78(3):907- 913.
16. Forsgren J, Samuelson A, Ahlin A, Jonasson J, Rynnel-Dagöö B, Lindberg A.
Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as
demonstrated by in situ hybridization and bacterial viability assay. Infect Immun. 1994,62(2):673-679.
17. Harmsen HJM, Gibson GR, Elfferich P, Raangs GC, Wildeboer-Veloo ACM, Argaiz A, Roberfroid MB, Welling GW. Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria. FEMS Microbiol Lett. 2000,183(1):125-129.
95 18. Garcia-Armisen T, Servais P. Enumeration of viable E. coli in rivers and wastewaters by
fluorescent in situ hybridization. J Microbiol Methods. 2004,58(2):269-279.
19. Keer JT, Birch L. Molecular methods for the assessment of bacterial viability. J Microbiol
Methods. 2003,53(2):175-183.
20. Neef A, Zaglauer A, Meier H, Amann R, Lemmer H, Schleifer K-H. Population analysis in a denitrifying sand filter: conventional and in situ identification of Paracoccus spp. in methanol-fed biofilms. Appl Environ Microbiol. 1996,62(12):4329-4339.
21. Manz W, Szewzyk U, Ericsson P, Amann R, Schleifer K, Stenström T. In situ identification of bacteria in drinking water and adjoining biofilms by hybridization with 16S and 23S rRNA-directed fluorescent oligonucleotide probes. Appl Environ Microbiol. 1993,59(7):2293-2298.
22. Markowitz VM, Szeto E, Palaniappan K, Grechkin Y, Chu K, Chen I-MA, Dubchak I, Anderson I, Lykidis A, Mavromatis K. The integrated microbial genomes (IMG) system in 2007: data content and analysis tool extensions. Nucleic Acids Res. 2007,36(suppl_1):D528-D533.
23. Craig R, Beavis RC. A method for reducing the time required to match protein sequences with tandem mass spectra. Rapid Commun Mass Spectrom. 2003,17(20):2310-2316. 24. Shteynberg D, Deutsch EW, Lam H, Eng JK, Sun Z, Tasman N, Mendoza L, Moritz RL,
Aebersold R, Nesvizhskii AI. iProphet: multi-level integrative analysis of shotgun proteomic data improves peptide and protein identification rates and error estimates.
Molecular & Cellular Proteomics. 2011,10(12):M111. 007690.
25. Vizcaíno JA, Côté RG, Csordas A, Dianes JA, Fabregat A, Foster JM, Griss J, Alpi E, Birim M, Contell J. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 2012,41(D1):D1063-D1069.
26. Vizcaíno JA, Deutsch EW, Wang R, Csordas A, Reisinger F, Rios D, Dianes JA, Sun Z, Farrah T, Bandeira N. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol. 2014,32(3):223-226.
27. Liu H, Sadygov RG, Yates JR. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem. 2004,76(14):4193-4201.
28. Kruh NA, Troudt J, Izzo A, Prenni J, Dobos KM. Portrait of a pathogen: the
Mycobacterium tuberculosis proteome in vivo. PLoS ONE. 2010,5(11):e13938.
29. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001,125(1):279-284.
30. Serres MH, Riley M. MultiFun, a multifunctional classification scheme for Escherichia
coli K-12 gene products. Microb Comp Genomics. 2000,5(4):205-222.
31. Alvarez Hayes J, Lamberti Y, Surmann K, Schmidt F, Volker U, Rodriguez ME. Shotgun proteome analysis of Bordetella pertussis reveals a distinct influence of iron availability on the bacterial metabolism, virulence, and defense response. Proteomics. 2015,15(13):2258-2266.
32. Bernhardt J, Michalik S, Wollscheid B, Völker U, Schmidt F. Proteomics approaches for the analysis of enriched microbial subpopulations and visualization of complex functional information. Curr Opin Biotechnol. 2013,24(1):112-119.
33. Overbeek R, Begley T, Butler RM, Choudhuri JV, Chuang H-Y, Cohoon M, de Crécy- Lagard V, Diaz N, Disz T, Edwards R. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res. 2005,33(17):5691-5702.
34. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010,26(7):966-968. 35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time
96
36. Brunelle JL, Green R, Coomassie blue staining, in Methods Enzymol. 2014, Elsevier. p. 161-167.
Capítulo 3
Estudio del proteoma de Bordetella
pertussis durante su adaptación al
entorno intracelular en macrófagos
humanos
99